MedTrace Logo

Chinese PE Multimodality Imaging Artificial Intelligence Study

NCT06526468 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-08-28

No results posted yet for this study

Summary

The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.

Conditions

  • Pulmonary Embolism
  • Chronic Thromboembolic Pulmonary Hypertension
  • Chronic Thromboembolic Pulmonary Disease

Interventions

DEVICE

Artificial Intelligence

AI technology will provide novel imaging markers and generate a radiology report with relevant key slice imaging and evaluation results

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    lead OTHER

Principal Investigators

  • Zhenguo Zhai, PhD · China-Japan Friendship Hospital

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-01
Primary Completion
2027-09-01
Completion
2028-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06526468 on ClinicalTrials.gov